Idorsia’s Tryvio deal delay; Galectin’s liver drug disappoints

Plus, news about Pyxis, Epitopea and Genevant:

Idorsia’s deal for blood pressure drug hits snag: The Swiss company

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Human gut microbiome: A source of new antibiotic peptides

Researchers identified 323 peptide-based antimicrobials from the human microbiome, with 71% showing significant antibacterial activity, and the lead peptide, prevotellin-2, matching the efficacy of polymyxin

August 25, 2024

Osteoporosis and aging linked at cellular level

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume

August 6, 2024

KLAS: Epic EHR Initiatives for Improving EHR Efficiency and User Satisfaction

What You Should Know: With limited budgets and resources, Arch Collaborative members frequently ask KLAS which of their EHR vendor’s education initiatives and system features

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.